These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 8065037)

  • 1. [Automated simultaneous measurements of activity and antigenicity of plasma antithrombin III].
    Tsushima C; Chiba H; Akizawa K; Araki K; Matsuno K; Kobayashi K
    Rinsho Byori; 1994 Jul; 42(7):713-7. PubMed ID: 8065037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional and antigenic antithrombin III values in plasma and serum from 115 regular blood donors and antithrombin III in prediction of postoperative thrombosis.
    Nilsen DW; Jeremic M; Weisert OK; Fønstelien E; Godal HC
    Thromb Haemost; 1983 Aug; 50(2):530-3. PubMed ID: 6415845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma and urinary heparin cofactor II levels in patients with nephrotic syndrome.
    Grau E; Oliver A; Félez J; Barceló P; Fernandez C; Ballarin JA; Fontcuberta J; Rutllant ML
    Thromb Haemost; 1988 Oct; 60(2):137-40. PubMed ID: 3217913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Thrombin-antithrombin III complexes in plasma and subretinal fluid in patients with perforated retinal detachment].
    Malukiewicz-Wiśniewska G; Kotschy M
    Klin Oczna; 2000; 102(4):267-70. PubMed ID: 11291298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical studies on plasma antithrombin III using an antiserum prepared in our laboratories.
    Cucuianu M; Cristea A; Vonica A; Lascu I
    Med Interne; 1988; 26(3):191-7. PubMed ID: 3187359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study of serum level of antithrombin-III antigen, antithrombin activity, and its ratio of AT-III-heparin complex formation in maintenance hemodialysis patients].
    Yoshida K; Saka M; Kaneko Y; Kubota K; Hirao Y; Okajima E; Ishida M; Kihouin K; Motomiya Y
    Nihon Jinzo Gakkai Shi; 1989 Nov; 31(11):1171-7. PubMed ID: 2625740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High plasma levels of protein C activity and antigen in the nephrotic syndrome.
    Mannucci PM; Valsecchi C; Bottasso B; D'Angelo A; Casati S; Ponticelli C
    Thromb Haemost; 1986 Feb; 55(1):31-3. PubMed ID: 3754658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antithrombin III activity in health cats and its changes in selected disease].
    Rivera Ramirez PA; Deniz A; Wirth W; Mischke R
    Berl Munch Tierarztl Wochenschr; 1997 Dec; 110(11-12):440-4. PubMed ID: 9451844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circadian rhythms of fibrinogen and antithrombin III in liver cirrhosis.
    Pasqualetti P; Casale R
    Riv Eur Sci Med Farmacol; 1995; 17(4):125-9. PubMed ID: 8545565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity-guided antithrombin III therapy in severe surgical sepsis: efficacy and safety according to a retrospective data analysis.
    Moubarak P; Zilker S; Wolf H; Hofner B; Kneib T; Küchenhoff H; Jauch KW; Hartl WH
    Shock; 2008 Dec; 30(6):634-41. PubMed ID: 18520701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparin elimination in patients with liver cirrhosis.
    Teien AN
    Thromb Haemost; 1977 Oct; 38(3):701-6. PubMed ID: 579516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma antithrombin III activity in normal pregnancy.
    Weiner CP; Brandt J
    Obstet Gynecol; 1980 Nov; 56(5):601-3. PubMed ID: 7432731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of platelet activation, plasma antithrombin III and alpha2-antiplasmin activities in hypertensive patients.
    Tomczykowska M; Bielak J; Bodys A
    Ann Univ Mariae Curie Sklodowska Med; 2003; 58(1):15-20. PubMed ID: 15314952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression and its clinical significance of tissue factor pathway inhibitor and antithrombin-III in patients with hepatic inflammatory diseases].
    Dong L; Peng Y; Wang R
    Zhonghua Gan Zang Bing Za Zhi; 1999 Dec; 7(4):224-5. PubMed ID: 10715793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breed, age, and gender differences in plasma antithrombin-III activity in clinically normal young horses.
    Johnstone IB; Physick-Sheard P; Crane S
    Am J Vet Res; 1989 Oct; 50(10):1751-3. PubMed ID: 2802307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antithrombin III activity and diabetes mellitus in the Ivory Coast population.
    Blavy G; N'Guessan R
    Nouv Rev Fr Hematol (1978); 1992; 34(4):315-6. PubMed ID: 1333072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein C, S and antithrombin III levels in patients with acute mechanical valve thrombosis.
    Tütün U; Ulus AT; Aksöyek A; Kaplan S; Ayaz S; Yilmaz S; Birincioglu L; Katircioglu SF
    Panminerva Med; 2002 Dec; 44(4):359-63. PubMed ID: 12434119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The response of antithrombin III activity after supplementation decreases in proportion to the severity of sepsis and liver dysfunction.
    Hayakawa M; Sawamura A; Yanagida Y; Sugano M; Hoshino H; Gando S
    Shock; 2008 Dec; 30(6):649-52. PubMed ID: 18496242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antithrombin III metabolism in the pulmonary vessel endothelium.
    Proietta M; Pulignano I; Del Porto F; Tritapepe L; Di Giovanni C; Caronti B; Guglielmi R; Aliberti G
    Blood Coagul Fibrinolysis; 2007 Apr; 18(3):237-40. PubMed ID: 17413759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Renal pathology in the Ivory Coast: exploration and functional activity of antithrombin iii].
    Blavy G; Kouame C
    Nephrologie; 1994; 15(6):387-9. PubMed ID: 7862227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.